Paper Details

  1. Home
  2. Paper Details

Adjuvant chemotherapy for operable breast cancer in postmenopausal women.

Author: FalksonG, FalksonH C, LouwE M, PortugalM A, SchoemanH S

Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

A study of 105 postmenopausal women with operable breast cancer found that adjuvant chemotherapy significantly improved survival rates. The study also identified specific patient groups who may benefit most from adjuvant chemotherapy.
Paper Details　
Original Abstract of the Article :
Survival figures of women with operable breast cancer reached a plateau 40 years ago. It was only with the advent of adjuvant chemotherapy that these figures showed a dramatic improvement. Data obtained in 105 postmenopausal women with operable breast cancer, treated at our clinic, are presented. Pa...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/6344266

データ提供：米国国立医学図書館（NLM）

Adjuvant Chemotherapy for Operable Breast Cancer in Postmenopausal Women: Optimizing Treatment Strategies

Breast cancer, a prevalent and complex disease, requires individualized and comprehensive treatment approaches. This study delves into the use of adjuvant chemotherapy for postmenopausal women with operable breast cancer, examining the effectiveness of various chemotherapy regimens in improving survival outcomes. The authors present data from a cohort of postmenopausal women who received adjuvant chemotherapy, comparing different protocols and exploring factors that influence treatment success.

Adjuvant Chemotherapy: A Key Component of Breast Cancer Management

The study demonstrates that adjuvant chemotherapy plays a crucial role in improving survival outcomes for postmenopausal women with operable breast cancer. The data highlight the importance of carefully selecting chemotherapy regimens based on individual patient characteristics and risk factors. This research underscores the need for tailored treatment approaches to optimize outcomes and improve the lives of women facing this challenging diagnosis.

Personalized Treatment Plans: A Foundation for Improved Outcomes

This study emphasizes the need for individualized treatment plans for breast cancer, taking into account each patient's unique characteristics and risk factors. It highlights the importance of ongoing research to refine treatment strategies and improve outcomes for postmenopausal women with breast cancer.

Dr.Camel's Conclusion

Just as a camel adapts its journey to the ever-changing desert landscape, breast cancer treatment requires a flexible and personalized approach. This study offers valuable insights into the role of adjuvant chemotherapy in improving survival outcomes for postmenopausal women with breast cancer, reminding us that research and innovation are key to addressing this complex disease.

Date :
  1. Date Completed 1983-07-08
  2. Date Revised 2014-09-12
Further Info :

Pubmed ID

6344266

DOI: Digital Object Identifier

6344266

Related Literature

Article Analysis
・Effective treatment of breast cancer
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.